MoonLake Immunotherapeuti... (MLTX)
NASDAQ: MLTX
· Real-Time Price · USD
54.42
-0.46 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
54.39
-0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT
MoonLake Immunotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 101.85K | 101.85K | 101.85K | 19.74K | 19.74K | 19.74K | 19.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.2M | 489.55K | 134.37K | 86.73K | 57.5K | 32.68K | 13.16K | 9.87K | 9.87K | 6.58K | 3.29K | 3.29K | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -1.1M | -387.7K | -32.52K | -66.99K | -37.77K | -12.94K | 6.58K | -9.87K | -9.87K | -6.58K | -3.29K | -3.29K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -200.88M | -170.76M | -143.09M | -108.54M | -78.4M | -61.01M | -54.12M | -55.79M | -57.58M | -62.05M | -65.06M | -50.59M | -42.09M | -57.12M | -41.27M | -39.14M | -32.88M | -194.87K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.82K | 32.73K | 32.73K | 32.73K |
Pretax Income | -178.74M | -147.46M | -120.96M | -82.45M | -58.02M | -45.68M | -43.98M | -52.6M | -55.74M | -60.8M | -64.47M | -50.23M | -41.79M | -57.07M | -41.27M | -39.14M | -32.85M | -162.13K |
Net Income | -176.47M | -145.51M | -118.94M | -80.77M | -54.8M | -40.68M | -39.22M | -33.72M | -39.04M | -46.31M | -49.97M | -50.26M | -41.81M | -57.08M | -41.27M | -39.14M | -32.85M | -162.13K |
Selling & General & Admin | 38.56M | 34.54M | 30.32M | 28.03M | 26.05M | 23.61M | 22.32M | 20.72M | 21.07M | 22.84M | 22.81M | 19.71M | 19.56M | 16.12M | 10.73M | 8.61M | 3.01M | 194.86K |
Research & Development | 161.57M | 136.19M | 112.72M | 80.46M | 52.3M | 37.37M | 31.8M | 35.07M | 36.51M | 39.21M | 42.25M | 42.98M | 34.62M | 53.09M | 42.64M | 30.54M | 29.87M | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.59K | 37.59K | 107.1K | 113.9K | 55.47K | 51.69K | -17.82K | -24.62K | -3.78K | n/a |
Operating Expenses | 200.13M | 170.73M | 143.04M | 108.49M | 78.35M | 60.99M | 54.12M | 55.79M | 57.58M | 62.05M | 65.06M | 50.59M | 42.09M | 57.12M | 41.27M | 39.14M | 32.88M | 194.86K |
Interest Expense | 2.02M | -18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.67M | -10.67M | -10.67M | -10.67M | n/a | n/a | n/a |
Cost & Expenses | 101.71M | 71.59M | 43.93M | 108.54M | 78.4M | 61.01M | 54.12M | 55.79M | 57.58M | 62.05M | 65.06M | 50.59M | 42.09M | 57.12M | 41.27M | 39.14M | 32.88M | 194.86K |
Income Tax Expense | 75.25K | 58.95K | 282.2K | 285.37K | 222.18K | 153.63K | 94.39K | 61.09K | 40.91K | 40.04K | 36.37K | 31.06K | 22.32K | 12.93K | 5.6K | -107 | -107 | n/a |
Shares Outstanding (Basic) | 63.28M | 63.23M | 63.07M | 62.9M | 62.87M | 62.64M | 59.91M | 53.52M | 43.72M | 39.06M | 38.84M | 36.93M | 35.2M | 36.93M | 14.8M | 36.93M | 36.93M | 14.8M |
Shares Outstanding (Diluted) | 63.28M | 63.23M | 63.07M | 62.9M | 62.87M | 62.64M | 59.91M | 53.52M | 43.72M | 39.06M | 38.84M | 36.93M | 35.2M | 36.93M | 14.8M | 36.93M | 36.93M | 14.8M |
EPS (Basic) | -2.78 | -2.3 | -1.89 | -1.29 | -0.91 | -0.75 | -0.84 | -0.77 | -0.99 | -1.25 | -1.37 | -1.47 | -1.24 | -1.64 | -1.22 | -1.07 | -0.9 | -0.01 |
EPS (Diluted) | -2.78 | -2.3 | -1.89 | -1.29 | -0.91 | -0.75 | -0.84 | -0.77 | -0.99 | -1.25 | -1.37 | -1.47 | -1.24 | -1.64 | -1.22 | -1.07 | -0.9 | -0.01 |
EBITDA | -181.32M | -158.69M | -138.48M | -108.45M | -78.35M | -60.98M | -54.11M | -55.78M | -57.57M | -62.04M | -65.05M | -50.58M | -42.08M | -57.11M | -41.17M | -39.03M | -32.77M | -85.84K |
EBIT | -183.77M | -160.43M | -139.87M | -108.54M | -78.4M | -61.01M | -54.12M | -55.79M | -57.58M | -62.05M | -65.06M | -50.59M | -42.08M | -57.11M | -41.25M | -39.11M | -32.84M | -162.13K |
Depreciation & Amortization | 2.45M | 1.74M | 1.38M | 86.73K | 57.5K | 32.68K | 13.16K | 13.16K | 13.16K | 13.16K | 12.36K | 12.55K | 11.53K | 8.35K | 61.07K | 72.51K | 70.24K | 70.13K |